Related Experiment Video

Updated: Jun 20, 2026

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

[Angiogenesis inhibitors and radiation therapy: from biology to clinical practice]

R Mazeron1, D Azria, E Deutsch

  • 1Département de Radiothérapie, Institut Gustave-Roussy, 94805 Villejuif, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|August 22, 2009
PubMed

Insights

Angiogenesis research is key in cancer. Combining therapies with irradiation shows promise by improving tumor oxygenation and radiosensitivity, though optimal treatment strategies require further investigation.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment

Context:

  • Angiogenesis, the formation of new blood vessels, is a critical process in cancer development and progression.
  • Recent advancements in understanding angiogenesis mechanisms have paved the way for novel anti-cancer therapies.
  • Inhibiting angiogenesis is a significant strategy in modern cancer research and treatment development.

Purpose:

  • To explore the synergistic effects of combining anti-angiogenic molecules with irradiation in cancer therapy.
  • To investigate the potential mechanisms behind this synergy, focusing on tumor vasculature normalization.
  • To identify key questions regarding optimal dosing and sequencing for combined modality treatments.

Summary:

  • Preclinical studies indicate that certain molecules enhance the efficacy of irradiation by temporarily normalizing tumor vasculature.
  • This normalization is hypothesized to improve tumor oxygenation, thereby increasing tumor cell radiosensitivity.
  • Several such molecular agents are currently undergoing early-phase clinical trials (Phase I/II).

Impact:

  • This research highlights a promising therapeutic approach for enhancing cancer treatment outcomes.
  • Understanding the nuances of combining anti-angiogenic therapies with radiation can lead to more effective and targeted cancer care.
  • Further research is crucial to optimize treatment protocols, including dosage and scheduling, for maximum clinical benefit.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...